← All trials
NCT05067946
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2021
- Primary completion
- Oct 31, 2022
- Completion date
- Oct 31, 2023
- First posted
- Oct 5, 2021
- Last posted
- Oct 5, 2021
- Enrollment
- 14000
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Genexine, Inc.Lead sponsor
- Kalbe Farma TBKCollaborator
- Genexine, Inc.Study director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.